Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Daubresse

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Obesity Research|July 1, 1996
Usefulness of fluoxetine in obese non-insulin-dependent diabetics: a multicenter studyJ C Daubresse, J Kolanowski, G Krzentowski, et al.
Diabete & Metabolisme|December 1, 1978
Pituitary-testicular axis in diabetic men with and without sexual impotenceJ C Daubresse, J C Meunier, J Wilmotte, et al.
European Journal of Clinical Investigation|March 31, 1976
Lipids and lipoproteins in chronic uraemia. A study of the influence of regular haemodialysisJ C Daubresse, G Lerson, G Plamteux, et al.
European Journal of Clinical Investigation|August 1, 1981
Lack of clinical and physiological relationship between gastrin and calcitonin in manG Heynen, A Brassine, J C Daubresse, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|December 1, 1992
Fluoxetine therapy in obese diabetic and glucose intolerant patientsM Kutnowski, J C Daubresse, H Friedman, et al.
Diabete & Metabolisme|June 1, 1987
The usefulness of fructosamine determination in diabetic patients and its relation to metabolic controlJ C Daubresse, E Laurent, C Ligny, et al.
Acta Diabetologica Latina|January 1, 1985
B-cell response to a standardized breakfast in end-stage renal failureJ C Daubresse, P Henrivaux, F Dehout, et al.
Acta Diabetologica Latina|July 1, 1980
Pancreatic B-cell response to a test-meal in lean and obese diabetic patients: relation to metabolic controlJ C Daubresse, A Bailly, C Lemy, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1987
Circulating inhibitor of factor VIII during treatment with teicoplanin and rifampicinJ C Legrand, P Van der Auwera, A Bailly, et al.
Bruxelles Medical|April 1, 1978
[What the physician should know about lactic acidosis and biguanides]M A Beaujean, M Muller, J C Daubresse, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Obesity Research|July 1, 1996
Usefulness of fluoxetine in obese non-insulin-dependent diabetics: a multicenter studyJ C Daubresse, J Kolanowski, G Krzentowski, et al.
Diabete & Metabolisme|December 1, 1978
Pituitary-testicular axis in diabetic men with and without sexual impotenceJ C Daubresse, J C Meunier, J Wilmotte, et al.
European Journal of Clinical Investigation|March 31, 1976
Lipids and lipoproteins in chronic uraemia. A study of the influence of regular haemodialysisJ C Daubresse, G Lerson, G Plamteux, et al.
European Journal of Clinical Investigation|August 1, 1981
Lack of clinical and physiological relationship between gastrin and calcitonin in manG Heynen, A Brassine, J C Daubresse, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|December 1, 1992
Fluoxetine therapy in obese diabetic and glucose intolerant patientsM Kutnowski, J C Daubresse, H Friedman, et al.
Diabete & Metabolisme|June 1, 1987
The usefulness of fructosamine determination in diabetic patients and its relation to metabolic controlJ C Daubresse, E Laurent, C Ligny, et al.
Acta Diabetologica Latina|January 1, 1985
B-cell response to a standardized breakfast in end-stage renal failureJ C Daubresse, P Henrivaux, F Dehout, et al.
Acta Diabetologica Latina|July 1, 1980
Pancreatic B-cell response to a test-meal in lean and obese diabetic patients: relation to metabolic controlJ C Daubresse, A Bailly, C Lemy, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1987
Circulating inhibitor of factor VIII during treatment with teicoplanin and rifampicinJ C Legrand, P Van der Auwera, A Bailly, et al.
Bruxelles Medical|April 1, 1978
[What the physician should know about lactic acidosis and biguanides]M A Beaujean, M Muller, J C Daubresse, et al.
Pageof 7